[Alternative production systems for therapeutic monoclonal antibodies].
Olivier
Stéphane
S
Vivalis SA, 6, rue Alain Bombard, 44800 Saint-Herblain, France. mehtali@vivalis.com
Mehtali
Majid
M
D000818:Animals; D030801:Animals, Genetically Modified; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000737:chemistry / Q000191:economics / Q000302:isolation & purification* / Q000627:therapeutic use; D001419:Bacteria; D001717:Birds; D016466:CHO Cells / Q000276:immunology; D002240:Carbohydrate Sequence; D002460:Cell Line / Q000276:immunology; D006224:Cricetinae; D003412:Cricetulus; D005658:Fungi; D006031:Glycosylation; D006801:Humans; D007313:Insecta; D008322:Mammals; D008969:Molecular Sequence Data; D004364:Pharmaceutical Preparations / Q000600:supply & distribution; D046549:Plantibodies / Q000302:isolation & purification / Q000627:therapeutic use; D030821:Plants, Genetically Modified; D011499:Protein Processing, Post-Translational; D013045:Species Specificity; D013678:Technology, Pharmaceutical / Q000191:economics / Q000379:methods*
D000911:Antibodies, Monoclonal; D004364:Pharmaceutical Preparations; D046549:Plantibodies